KEAP1 and neoplasm: Finally, the subcutaneous tumor formation experiments in nude mice using the H1975 wildtype and KEAP1-knockdown cells further confirmed that the sensitivity of NSCLC cells to the AURKA inhibitor MLN8237 was significantly enhanced after KEAP1 knockdown (Fig. 2H).